Quick Answer
Clearside Biomedical, Inc. reported Revenue (ASC 606) of $1.66 million for fiscal year 2024.
Clearside Biomedical, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2024 | $1.66M | -79.8% |
| 2023 | $8.23M | +519.9% |
| 2022 | $1.33M | -95.5% |
| 2021 | $29.57M | +274.7% |
| 2020 | $7.89M | +263.3% |
| 2019 | $2.17M | +7143.3% |
| 2018 | $30.0K | -91.3% |
| 2017 | $345.0K | -33.7% |
| 2016 | $520.0K | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $201.0K | -80.6% | -59.1% |
| June 30, 2025 | $492.0K | +446.7% | -78.9% |
| March 31, 2025 | $2.33M | +913.0% | +124.5% |
| September 30, 2024 | $1.04M | +20.8% | +1053.3% |
| June 30, 2024 | $90.0K | -91.2% | -60.9% |
| March 31, 2024 | $230.0K | +5650.0% | -73.2% |
| September 30, 2023 | $859.0K | +222.9% | -15.6% |
| June 30, 2023 | $1.02M | +165.1% | +25350.0% |
- Clearside Biomedical, Inc. showed a decrease of -79.8% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2024 period, Clearside Biomedical, Inc.’s revenue (asc 606) has grown by 220.0% (from $520.0 thousand to $1.66 million).
- The most recent figure is from Clearside Biomedical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: